Luye Pharma Group Ltd. (HKG:2186)

Luye Pharma Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	11,265	10,945	8,163	14,031	12,992	12,607
Market Cap Growth	30.20%	34.08%	-41.82%	8.00%	3.05%	7.49%
Enterprise Value	15,948	16,301	12,502	17,078	18,013	16,610
Last Close Price	2.82	2.74	2.17	3.73	3.66	3.56
PE Ratio	15.96	15.90	16.26	23.91	19.00	-
Forward PE	14.00	12.80	8.49	17.57	17.45	8.01
PS Ratio	1.60	1.56	1.26	2.07	1.92	1.98
PB Ratio	0.55	0.54	0.49	0.94	1.04	1.13
P/TBV Ratio	1.23	1.20	1.00	1.91	2.43	3.00
P/FCF Ratio	-	-	-	13.23	11.51	-
P/OCF Ratio	-	-	45.72	7.98	6.95	56.32
PEG Ratio	-	0.84	0.84	0.84	0.84	0.84
EV/Sales Ratio	2.27	2.32	1.94	2.52	2.66	2.60
EV/EBITDA Ratio	7.43	7.47	6.21	9.98	11.18	14.92
EV/EBIT Ratio	12.21	12.16	10.34	17.47	20.19	37.24
EV/FCF Ratio	-	-	-	16.10	15.96	-
Debt / Equity Ratio	0.51	0.51	0.66	0.62	0.83	1.04
Debt / EBITDA Ratio	4.80	4.80	5.38	5.33	6.27	10.09
Debt / FCF Ratio	-	-	-	8.75	9.12	-
Net Debt / Equity Ratio	0.11	0.11	0.24	0.17	0.32	0.44
Net Debt / EBITDA Ratio	0.98	0.98	2.02	1.49	2.50	4.39
Net Debt / FCF Ratio	-	-	-8.96	2.41	3.57	-10.65
Asset Turnover	0.20	0.20	0.22	0.25	0.26	0.24
Inventory Turnover	2.30	2.30	2.32	2.42	2.42	2.66
Quick Ratio	1.08	1.08	1.01	1.08	0.83	1.08
Current Ratio	1.53	1.53	1.24	1.32	1.14	1.42
Return on Equity (ROE)	4.14%	4.14%	4.41%	4.39%	5.79%	-1.68%
Return on Assets (ROA)	2.41%	2.41%	2.58%	2.23%	2.11%	1.05%
Return on Invested Capital (ROIC)	4.44%	4.52%	4.93%	4.49%	4.96%	2.82%
Return on Capital Employed (ROCE)	5.30%	5.30%	6.00%	5.10%	5.30%	2.40%
Earnings Yield	6.11%	6.29%	6.15%	4.18%	5.26%	-1.31%
FCF Yield	-	-	-5.56%	7.56%	8.69%	-3.64%
Buyback Yield / Dilution	-3.57%	-3.57%	-0.89%	-7.11%	-1.03%	-7.87%
Total Shareholder Return	-3.57%	-3.57%	-0.89%	-7.11%	-1.03%	-7.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.